May 16, 2021
Share no-repeat;center top;; auto AFLIBERCEPT (EYLEA) icon icon-info fadeInDown Text EYLEA enables proactive therapy approved for multiple retinal diseases. EYLEA is the only anti-angiogenic therapy […]
Anti-VEGF – Anti-Vascular Endothelial Growth Factor: Aflibercept (Eylea), Ranibizumab (Lucentis), Bevacizumab (Avastin) intravitreal injections.